In an 18-year-old thin female with bilateral ant‑biting paresthesias in the ventral hands and posterior feet, what is the likely cause, diagnosis, and recommended treatment with dosages?

Peripheral Neuropathy (Likely Nutritional or Idiopathic)

This 18-year-old thin female most likely has a peripheral sensory neuropathy, and first-line treatment should be nortriptyline 10-25 mg at bedtime, titrated up to 75-100 mg/day over 4-6 weeks, or alternatively gabapentin 300 mg at bedtime, titrated to 900-3600 mg/day in divided doses.

Diagnosis

The bilateral "ant-biting" paresthesias (formication) in a glove-and-stocking distribution (ventral hands and posterior feet) strongly suggests a length-dependent peripheral sensory neuropathy 1. The thin body habitus raises concern for nutritional deficiencies (B12, thiamine, folate) or eating disorders as potential causes.

Key Diagnostic Steps

• Blood work: Complete metabolic panel, HbA1c, vitamin B12, folate, thiamine levels, thyroid function
• Nerve conduction studies: May be needed if diagnosis unclear, though can be normal in small fiber neuropathy 1
• Rule out diabetes, alcohol use, medication-induced causes, and autoimmune conditions 1

Important caveat: The description is NOT consistent with actual insect bites or hypersensitivity reactions 2, which would present with localized reactions at sting sites, not bilateral symmetric paresthesias.

Treatment Algorithm

Step 1: Address Underlying Cause

• Correct any nutritional deficiencies identified
• Optimize glycemic control if diabetic
• Modify lifestyle factors (alcohol, diet) 1

Step 2: First-Line Pharmacological Treatment 3

Option A (Preferred for young patients): Gabapentin or Pregabalin

• Gabapentin: Start 300 mg at bedtime, increase to 300 mg TID after 1-3 days, then titrate by 300 mg/day every 3-7 days to target 900-3600 mg/day in 3 divided doses
• Pregabalin: Start 75 mg BID, increase to 150 mg BID after 1 week, maximum 300 mg BID

Option B: Tricyclic Antidepressants (TCAs)

• Nortriptyline (preferred over amitriptyline due to fewer side effects): Start 10-25 mg at bedtime, increase by 10-25 mg weekly to 75-100 mg/day
• Desipramine: Similar dosing to nortriptyline
• Requires 6-8 weeks for adequate trial, including 2 weeks at maximum tolerated dose 3
• Obtain baseline ECG if using TCAs (cardiac toxicity concern, though less relevant in 18-year-old) 3

Option C: SNRIs

• Duloxetine: Start 30 mg daily, increase to 60 mg daily after 1 week (maximum 60 mg/day for neuropathic pain)
• Venlafaxine: Start 37.5 mg daily, titrate to 150-225 mg/day

Step 3: Reassess at 4-8 Weeks 3

• If pain reduced to ≤3/10: Continue current therapy
• If pain remains ≥4/10 with partial relief: Add a second first-line medication from different class (e.g., gabapentin + nortriptyline)
• If <30% pain reduction: Switch to alternative first-line medication

Step 4: Refractory Cases

• Consider referral to neurology or pain specialist 3
• Second-line options include opioids or tramadol (use cautiously in young patients)

Clinical Pearls

• TCAs have anticholinergic side effects (dry mouth, constipation, urinary retention, orthostatic hypotension) - minimize by starting low, going slow, and dosing at bedtime 3
• Gabapentin/pregabalin may be better tolerated in young, thin patients with fewer drug interactions
• The analgesic effect of TCAs is independent of antidepressant effects 3
• Even with thorough workup, the underlying cause may remain elusive in many peripheral neuropathy cases 1